Lonza launches new non-endotoxin pyrogen detection system
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
The rally attracted around 250 riders, including professionals and amateurs.
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
AstraZeneca also played a critical role in the global response to COVID-19.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
Subscribe To Our Newsletter & Stay Updated